XLON
ICON
Market cap390kUSD
Oct 09, Last price
1.57GBP
1D
-7.65%
1Q
-4.85%
Jan 2017
-88.98%
IPO
-86.78%
Name
Iconic Labs PLC
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
114.64%
Rev. gr., 5y
54.20%
Revenues
0
Net income
-628k
L
CFO
-448k
L-44.18%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Iconic Labs Plc functions as a media and technology enterprise, primarily concentrating on digital marketing solutions and developing products powered by content and advanced technology. The company also engages in digital and social media publishing. It provides specialized advisory services to its clientele, manages and executes strategic campaigns, and delivers innovative creative services. Core operational activities encompass generating monthly insights, creating and distributing content, conducting thorough post-campaign analyses, and integrating with various online media brands. Founded in London, United Kingdom, in 2012, the firm was previously known as WideCells Group PLC before rebranding to Iconic Labs Plc in July 2019.
Key people
John Farquharson
Interim Chief Executive Officer, Director · since 2024
Victor Humberdot
Non-Executive Director · since 2024
Bela Lendvai-Lintner
Non-Executive Director · since 2024
Legal address
7 BELL YARD
LONDON, LND WC2A 2JR
GB
LONDON, LND WC2A 2JR
GB
Headquarters
MAPPIN HOUSE
4 WINSLEY STREET
LONDON, LND W1W 8HF
GB
4 WINSLEY STREET
LONDON, LND W1W 8HF
GB
Previous name
WIDECELLS GROUP LIMITED
Previous name
WIDECELLS GROUP PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||